Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.55 and traded as low as $0.44. Northwest Biotherapeutics shares last traded at $0.44, with a volume of 1,151,307 shares traded.
Northwest Biotherapeutics Trading Down 2.0 %
The stock’s 50-day simple moving average is $0.46 and its 200-day simple moving average is $0.55. The firm has a market capitalization of $540.81 million, a P/E ratio of -6.28 and a beta of -0.63.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last issued its quarterly earnings data on Friday, May 10th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.28 million for the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- P/E Ratio Calculation: How to Assess Stocks
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
